JPMorgan Financial Files 424B2 Pricing Supplement for New Securities

TL;DR

**JPM Financial just filed a pricing supplement for new securities, standard bank financing.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026. This filing is a 'pricing supplement,' which typically details the final terms of a securities offering, such as bonds or notes. While the specific terms aren't in this snippet, it indicates JPMorgan Chase Financial Co. LLC is actively raising capital or structuring new financial products, which is a routine part of a large bank's operations to manage its balance sheet and fund its activities. For investors, this means the company is engaging in normal course financing, which can impact its debt levels and future interest expenses.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC is issuing new securities, which could affect the company's capital structure and future financial obligations.

Risk Assessment

Risk Level: low — This filing is a routine disclosure for a large financial institution detailing a securities offering, not an indicator of unusual risk.

Analyst Insight

Investors should note this as a routine financing activity for JPMorgan Chase Financial Co. LLC. While this specific filing doesn't detail the terms, smart investors would look for the full pricing supplement to understand the type, amount, and interest rates of the new securities, as these details could impact the company's future earnings and debt profile.

Key Numbers

• 424B2 — Form Type (Indicates a prospectus for a securities offering)
• 2026-03-24 — Filing Date (Date the document was filed with the SEC)
• 333-270004-01 — File No. (Registration statement number for JPMorgan Chase Financial Co. LLC's offering)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMorgan Chase & Co. (company) — Parent company of the filer
• March 24, 2026 (date) — Filing and acceptance date of the 424B2
• 0001665650 (person|company|dollar_amount) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person|company|dollar_amount) — CIK of JPMorgan Chase & Co.

FAQ

Key Financial Figures

• $1,947,000 — l Company LLC Structured Investments $1,947,000 Auto Callable Contingent Interest Not
• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $6.50 — roceeds to Issuer Per note $1,000 $6.50 $993.50 Total $1,947,000 $12,65
• $993.50 — to Issuer Per note $1,000 $6.50 $993.50 Total $1,947,000 $12,655.50 $1,
• $12,655.50 — $6.50 $993.50 Total $1,947,000 $12,655.50 $1,934,344.50 (1) See "Supplemental
• $1,934,344.50 — .50 Total $1,947,000 $12,655.50 $1,934,344.50 (1) See "Supplemental Use of Proceeds
• $954.10 — en the terms of the notes were set, was $954.10 per $1,000 principal amount note. See "
• $10.2083 — a Contingent Interest Payment equal to $10.2083 (equivalent to a Contingent Interest Ra
• $245.0000 — tal Contingent Interest Payments 24 $245.0000 23 $234.7917 22 $224.5833 21
• $234.7917 — terest Payments 24 $245.0000 23 $234.7917 22 $224.5833 21 $214.3750 20
• $224.5833 — 24 $245.0000 23 $234.7917 22 $224.5833 21 $214.3750 20 $204.1667 19
• $214.3750 — 23 $234.7917 22 $224.5833 21 $214.3750 20 $204.1667 19 $193.9583 18
• $204.1667 — 22 $224.5833 21 $214.3750 20 $204.1667 19 $193.9583 18 $183.7500 17
• $193.9583 — 21 $214.3750 20 $204.1667 19 $193.9583 18 $183.7500 17 $173.5417 16
• $183.7500 — 20 $204.1667 19 $193.9583 18 $183.7500 17 $173.5417 16 $163.3333 15

Filing Documents

• form424b2.htm (424B2) — 227KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 159KB
• image_003.gif (GRAPHIC) — 5KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-007944.txt ( ) — 595KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $1,947,000 Auto Callable Contingent Interest Notes Linked to the MerQube US Tech+ Vol Advantage Index due March 23, 2028 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for which the closing level of the MerQube US Tech+ Vol Advantage Index, which we refer to as the Index, is greater than or equal to 70.00% of the Initial Value, which we refer to as the Interest Barrier. The notes will be automatically called if the closing level of the Index on any Review Date (other than the first through eleventh and final Review Dates) is greater than or equal to the Initial Value. The earliest date on which an automatic call may be initiated is March 22, 2027. Investors should be willing to accept the risk of losing up to 85.00% of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Review Dates. Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments. The Index is subject to a 6.0% per annum daily deduction, and the performance of the Invesco QQQ Trust SM , Series 1 (the "QQQ Fund") is subject to a notional financing cost. These deductions will offset any appreciation of the components of the Index, will heighten any depreciation of those components and will generally be a drag on the performance of the Index. The Index will trail the performance of an identical index without such deductions. See "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include a 6.0% per Annum Daily Deduction" and "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include the Deduction of a Notional Financing Cost" in this pricing supplement. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660R5V2 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement, "Risk Factors" beginning on page US-4 of the accompanying underlying supplement and "Selected Risk Considerations" beginning on page PS-7 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $6.50 $993.50 Total $1,947,000 $12,655.50 $1,934,344.50 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $6.50 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $954.10 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-III dated March 5, 2025, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Index: The MerQube US Tech+ Vol Advantage Index (Bloomberg ticker: MQUSTVA). Th

View Full Filing

View this 424B2 filing on SEC EDGAR